NovaBay Pharmaceuticals, Inc. (NBY): Price and Financial Metrics
NovaBay Pharmaceuticals, Inc. (NBY)
Today's Latest Price: $0.75 USD
0.05 (-6.70%)
Updated Apr 7 6:40pm
Add NBY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
NBY Stock Summary
- Revenue growth over the past 12 months for NovaBay Pharmaceuticals Inc comes in at -43.94%, a number that bests only 4.13% of the US stocks we're tracking.
- The volatility of NovaBay Pharmaceuticals Inc's share price is greater than that of 91.49% US stocks with at least 200 days of trading history.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for NBY comes in at -42.91% -- higher than that of merely 11.94% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to NovaBay Pharmaceuticals Inc, a group of peers worth examining would be BTN, UVE, LCII, CLCT, and MMI.
- NBY's SEC filings can be seen here. And to visit NovaBay Pharmaceuticals Inc's official web site, go to www.novabay.com.
NBY Daily Price Range
NBY 52-Week Price Range
NBY Stock Price Chart More Charts
NBY Price/Volume Stats
| Current price | $0.75 | 52-week high | $4.04 |
| Prev. close | $0.81 | 52-week low | $0.23 |
| Day low | $0.73 | Volume | 1,027,400 |
| Day high | $0.79 | Avg. volume | 2,188,375 |
| 50-day MA | $0.61 | Dividend yield | N/A |
| 200-day MA | $0.74 | Market Cap | 21.11M |
NovaBay Pharmaceuticals, Inc. (NBY) Company Bio
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products for the eye care market in the United States. The company was founded in 2000 and is based in Emeryville, California.
Top Stories View All
Best & Worst Performing Stock Industries for April 7, 2020
Best & Worst Performing Small Cap Stocks for April 7, 2020
Best & Worst Performing Mid Cap Stocks for April 7, 2020
Best & Worst Performing Large Cap Stocks for April 7, 2020
Best & Worst Performing Mega Cap Stocks for April 7, 2020
View All Top Stories
Loading social stream, please wait...